Sorry, you need to enable JavaScript to visit this website.

Pfizer CentreOne wins 2017 CMO Leadership Award

Thursday, February 2, 2017
Announcement

Customer feedback by Big and Small Pharma basis for recognition of service excellence

Pfizer CentreOne, a global contract manufacturing organization embedded within Pfizer, today announced that it has been named a recipient of Life Science Leader’s 2017 CMO Leadership Awards, now in its sixth year.

To determine recipients, Life Science Leader magazine teamed up with Industry Standard Research (ISR). More than 80 contract manufactures were assessed by 26 performance metrics in ISR’s annual Contract Manufacturing Quality Benchmarking survey.

Survey participants were recruited from pharma and biopharma companies of all sizes and were screened for decision-making influence related to working with contract manufacturing suppliers. Respondents only evaluate companies with which they have worked on an outsourced project within the past 18 months. This level of qualification ensures that survey responses are based on actual involvement with contract manufacturers and clear experiential data. Winners are judged by their customers as either exceeding expectations or as top performers.

Pfizer CentreOne won in the following categories:

Overall

  • Quality
  • Reliability
  • Capabilities
  • Expertise
  • Compatibility
  • Development

Big Pharma

  • Quality
  • Reliability
  • Capabilities
  • Expertise
  • Compatibility

Small Pharma

  • Quality
  • Reliability
  • Capabilities
  • Expertise
  • Compatibility

Said Peter Stevenson, vice president and general manager of Pfizer CentreOne, “We’re honored to be recognized by pharmaceutical companies big and small. In fact, up to 70 percent of our biopharma partners start out with us as small to mid-sized companies. As a global contract manufacturer embedded within Pfizer, we leverage Pfizer’s experience with 600 medicines in more than 160 markets on behalf of our biopharmaceutical partners, regardless of their size, while focusing on their individual technical, cultural and business needs.”

About Pfizer CentreOne: A global contract manufacturer embedded within Pfizer, Pfizer CentreOne focuses on API synthesis, sterile injectables fill-finish and highly potent solids. Formed by the union of Pfizer CentreSource, a global leader in specialty APIs, and Hospira One 2 One, one of the world’s premier sterile-injectables CMOs, Pfizer CentreOne has more than 40 years’ experience manufacturing complex compounds for biopharmaceutical partners. For more information, visit www.pfizercentreone.com.

Questions? Please contact Kristen Berg, Communications Manager, Pfizer CentreOne, [email protected], 224-212-5466.